ebola

Documents about ebola

• Experimental Vaccine for Prevention of Ebola Virus Infection#414372ClinicalTrials.gov
• Whose fears count? Legitimacy, trust and viral outbreak responses after COVID-19#393156PLOS
• African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola#125909ClinicalTrials.gov
• Fear, stigma and Uncertainty: The short and long-term effects of Ebola on survivors, affected families, and community in Bundibugyo, Western Uganda#672183PLOS
• EBOla Post-Exposure Prophylaxis#245567ClinicalTrials.gov
• REVIVE (Response to the Ebola Virus Vaccine)#353345ClinicalTrials.gov
• Note contextuelle sur l’épidémie d’Ebola Bundibugyo en Ituri (2026)#226980HAL (France)
• Contextual Note on the Ebola Bundibugyo Outbreak in Ituri (2026)#226988HAL (France)
• Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)#18697ClinicalTrials.gov
• Experimental Ebola Vaccine Trial#121433ClinicalTrials.gov
• R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease#917776ClinicalTrials.gov
• A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV#261336ClinicalTrials.gov
• Between the Extraordinary and the Everyday: Embodied Memory and Epidemic Preparedness During Ebola Outbreaks in Guinea#121835HAL (France)
• Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda#968427ClinicalTrials.gov
• A Study in Tanzania of a New Vaccine Against Two Types of Ebola#908215ClinicalTrials.gov
• Ebola and Marburg Virus Vaccines#901254ClinicalTrials.gov
• Controlling Ebola Trials#753693PhilArchive
• Efficacy of Favipiravir Against Ebola (JIKI)#217068ClinicalTrials.gov
• Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)#261362ClinicalTrials.gov
• A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants#901804ClinicalTrials.gov
• Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response#148782ClinicalTrials.gov
• Contextual note: Funeral practices in Ituri#250432HAL (France)
• Note contextuelle : Les pratiques funéraires en Ituri#250449HAL (France)
• Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC#459971ClinicalTrials.gov
• Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment#860756ClinicalTrials.gov
• Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)#832388ClinicalTrials.gov
• cmmid/ebola-importation#374990LSHTM Data Compass
• Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)#146254ClinicalTrials.gov
• Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon#287392ClinicalTrials.gov
• Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up#872629ClinicalTrials.gov
• Managing DRC’s Ebola Crisis#290821Center for Strategic and International Studies
• A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.#424244ClinicalTrials.gov
• Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo#426628ClinicalTrials.gov
• Ebola virus and Sudan virus infection in humans: a comparison to inform vaccine research and development#642677Europe PMC
• Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)#913398ClinicalTrials.gov
• Ebola at a critical juncture: preparedness must outpace transmission#349389WHO IRIS
• Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)#152516ClinicalTrials.gov
• Ebola in the DRC: A different problem compounded by violence#437350PLOS
• A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.#882001ClinicalTrials.gov
• EBOVAC-Salone Extension#180202ClinicalTrials.gov
• Infection prevention and control guideline for Ebola and Marburg diseases#294959NCBI Bookshelf
• Ebola Virus Disease Democratic Republic of Congo: External Situation Report 22#139616WHO IRIS
• Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)#311196ClinicalTrials.gov
• An Ebola-Like Microbe and The Limits of Kind-Based Goodness#74317PhilArchive
• Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults#390969ClinicalTrials.gov
• Infection prevention and control guideline for Ebola and Marburg diseases#195141World Health Organization
• airport_screening_ebola_bvd: Effectiveness of airport screening for Bundibugyo ebolavirus#399497LSHTM Data Compass
• A smart phone based expert system for airport screening of infectious diseases : test case with the Ebola virus symptoms#938651SU+ Digital Repository
• Ebola at a critical juncture: preparedness must outpace transmission.#330866NCBI PubMed Central
• The mental health professional at the feet of the Ebola virus: individual treatment and global mental challenges#250234HAL (France)